Published in J Cell Biol on October 13, 2003
In situ elasticity modulation with dynamic substrates to direct cell phenotype. Biomaterials (2009) 2.41
Integrin alpha3beta1-dependent beta-catenin phosphorylation links epithelial Smad signaling to cell contacts. J Cell Biol (2009) 1.58
Enhanced myofibroblastic differentiation and survival in Thy-1(-) lung fibroblasts. Am J Respir Cell Mol Biol (2006) 1.54
A TRPC6-dependent pathway for myofibroblast transdifferentiation and wound healing in vivo. Dev Cell (2012) 1.29
Myofibroblasts: trust your heart and let fate decide. J Mol Cell Cardiol (2013) 1.25
Statins block calcific nodule formation of valvular interstitial cells by inhibiting alpha-smooth muscle actin expression. Arterioscler Thromb Vasc Biol (2009) 1.16
Structural components of the nonstriated contractile apparatuses in the Caenorhabditis elegans gonadal myoepithelial sheath and their essential roles for ovulation. Dev Dyn (2007) 0.88
Molecular networks underlying myofibroblast fate and fibrosis. J Mol Cell Cardiol (2016) 0.81
Mechanisms of muscle gene regulation in the electric organ of Sternopygus macrurus. J Exp Biol (2013) 0.77
Unidentified cells reside in fish skeletal muscle. Cytotechnology (2008) 0.75
Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol (2002) 14.80
The mechanism of muscular contraction. Science (1969) 14.47
Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature (2000) 8.59
Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol (1993) 8.36
Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu Rev Cell Dev Biol (1998) 7.31
Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. Proc Natl Acad Sci U S A (1989) 7.19
Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo. Cell (1991) 6.48
Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia (1971) 5.14
A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. Genes Dev (1998) 5.14
Myofibroblasts. I. Paracrine cells important in health and disease. Am J Physiol (1999) 4.99
Fibroblasts, myofibroblasts, and wound contraction. J Cell Biol (1994) 4.60
Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Mol Biol Cell (2001) 4.25
Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases. Proc Natl Acad Sci U S A (2000) 4.08
Mechanisms of myofibroblast activity and phenotypic modulation. Exp Cell Res (1999) 3.78
PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis. Cell (1996) 3.60
Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis. Proc Natl Acad Sci U S A (2000) 3.47
The myofibroblast in pulmonary fibrosis. Chest (2002) 3.46
Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors. Proc Natl Acad Sci U S A (1996) 3.24
Induction of alpha-smooth muscle actin by transforming growth factor-beta 1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia. Lab Invest (1993) 2.89
A small-molecule inhibitor of skeletal muscle myosin II. Nat Cell Biol (2002) 2.78
Transforming growth factor-beta1 promotes the morphological and functional differentiation of the myofibroblast. Exp Cell Res (2000) 2.38
The mammalian myosin heavy chain gene family. Annu Rev Cell Dev Biol (1996) 2.20
Paired MyoD-binding sites regulate myosin light chain gene expression. Proc Natl Acad Sci U S A (1991) 2.14
Are stress fibres contractile? Nature (1981) 2.10
The NH2-terminal peptide of alpha-smooth muscle actin inhibits force generation by the myofibroblast in vitro and in vivo. J Cell Biol (2002) 1.82
Dependence of collagen remodelling on alpha-smooth muscle actin expression by fibroblasts. J Cell Physiol (1994) 1.77
Fibroblast contraction occurs on release of tension in attached collagen lattices: dependency on an organized actin cytoskeleton and serum. Anat Rec (1992) 1.72
In vitro and in vivo activation of rat hepatic stellate cells results in de novo expression of L-type voltage-operated calcium channels. Hepatology (2001) 1.66
Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo. J Clin Invest (1993) 1.63
Isolation and contraction of the stress fiber. Mol Biol Cell (1998) 1.61
The hepatic stellate (Ito) cell: its role in human liver disease. Virchows Arch (1997) 1.54
Dual structural and functional phenotypes of the porcine aortic valve interstitial population: characteristics of the leaflet myofibroblast. J Surg Res (1994) 1.42
Different pathways regulate expression of the skeletal myosin heavy chain genes. J Biol Chem (2001) 1.38
A 29-nucleotide DNA segment containing an evolutionarily conserved motif is required in cis for cell-type-restricted repression of the chicken alpha-smooth muscle actin gene core promoter. Mol Cell Biol (1988) 1.29
The 5'-flanking region of the mouse vascular smooth muscle alpha-actin gene contains evolutionarily conserved sequence motifs within a functional promoter. J Biol Chem (1990) 1.25
Thy1 (+) and (-) lung fibrosis subpopulations in LEW and F344 rats. Eur Respir J (1994) 1.22
Elements of the smooth muscle alpha-actin promoter required in cis for transcriptional activation in smooth muscle. Evidence for cell type-specific regulation. J Biol Chem (1992) 1.20
An E-box within the MHC IIB gene is bound by MyoD and is required for gene expression in fast muscle. Am J Physiol (1999) 1.19
Molecular mechanisms of pulmonary fibrosis. Front Biosci (2002) 1.17
Sarcomeric gene expression and contractility in myofibroblasts. J Cell Biol (1997) 1.15
MyoD-positive myoblasts are present in mature fetal organs lacking skeletal muscle. J Cell Biol (2001) 1.08
Evolutionarily conserved sequences of striated muscle myosin heavy chain isoforms. Epitope mapping by cDNA expression. J Biol Chem (1989) 1.08
Intracellular calcium and myosin isoform transitions. Calcineurin and calcium-calmodulin kinase pathways regulate preferential activation of the IIa myosin heavy chain promoter. J Biol Chem (2002) 1.07
MEF-2 and Oct-1 bind to two homologous promoter sequence elements and participate in the expression of a skeletal muscle-specific gene. J Biol Chem (1998) 1.07
The cxc chemokine cCAF stimulates differentiation of fibroblasts into myofibroblasts and accelerates wound closure. J Cell Biol (2002) 1.05
Myofibroblasts: molecular crossdressers. Curr Top Dev Biol (2001) 1.01
The deletion of transforming growth factor-beta-induced myofibroblasts depends on growth conditions and actin organization. Am J Pathol (1999) 0.99
Myogenic regulatory factors can activate TATA-containing promoter elements via an E-box independent mechanism. J Biol Chem (1995) 0.99
Transcriptional regulatory elements in the 5' upstream and first intron regions of the human smooth muscle (aortic type) alpha-actin-encoding gene. Gene (1991) 0.91
Human wound healing fibroblasts have greater contractile properties than dermal fibroblasts. J Surg Res (1994) 0.91
The myofibroblast as an inflammatory cell in pulmonary fibrosis. Curr Top Pathol (1999) 0.90
Transcriptional regulation of a contractile gene by mechanical forces applied through integrins in osteoblasts. J Biol Chem (2002) 0.90
Lineage restriction of the myogenic conversion factor myf-5 in the brain. Development (1995) 0.88
Myofibroblast: a prognostic marker and target cell in progressive renal disease. Ren Fail (2001) 0.84
Expression of sarcomeric proteins and assembly of myofibrils in the putative myofibroblast cell line BHK-21/C13. J Muscle Res Cell Motil (1998) 0.79
Interstitial cellular and matrix restoration of cardiac valves after cryopreservation. J Thorac Cardiovasc Surg (1999) 0.77
Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation (2006) 4.69
Valvular myofibroblast activation by transforming growth factor-beta: implications for pathological extracellular matrix remodeling in heart valve disease. Circ Res (2004) 2.45
A PGC-1α isoform induced by resistance training regulates skeletal muscle hypertrophy. Cell (2012) 2.35
The TEL patch of telomere protein TPP1 mediates telomerase recruitment and processivity. Nature (2012) 2.33
Evidence that opioids may have toll-like receptor 4 and MD-2 effects. Brain Behav Immun (2009) 2.19
Genetic variability in forced and voluntary endurance exercise performance in seven inbred mouse strains. J Appl Physiol (1985) (2002) 2.15
Exercise can prevent and reverse the severity of hypertrophic cardiomyopathy. Circ Res (2006) 2.09
Gene mutations and genomic rearrangements in the mouse as a result of transposon mobilization from chromosomal concatemers. PLoS Genet (2006) 1.84
Future research directions in idiopathic pulmonary fibrosis: summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Med (2002) 1.76
Controlling pathological pain by adenovirally driven spinal production of the anti-inflammatory cytokine, interleukin-10. Eur J Neurosci (2005) 1.73
Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats. Brain Behav Immun (2006) 1.67
Controlling neuropathic pain by adeno-associated virus driven production of the anti-inflammatory cytokine, interleukin-10. Mol Pain (2005) 1.66
Repeated intrathecal injections of plasmid DNA encoding interleukin-10 produce prolonged reversal of neuropathic pain. Pain (2006) 1.66
The cell biology of disease: cellular mechanisms of cardiomyopathy. J Cell Biol (2011) 1.54
Hibernating squirrel muscle activates the endurance exercise pathway despite prolonged immobilization. Exp Neurol (2013) 1.52
Crosslinked hyaluronan scaffolds as a biologically active carrier for valvular interstitial cells. Biomaterials (2005) 1.51
Competencies: a cure for pre-med curriculum. Science (2011) 1.47
Designing scaffolds for valvular interstitial cells: cell adhesion and function on naturally derived materials. J Biomed Mater Res A (2004) 1.43
Uncoupling of expression of an intronic microRNA and its myosin host gene by exon skipping. Mol Cell Biol (2010) 1.43
Molecular consequences of the R453C hypertrophic cardiomyopathy mutation on human β-cardiac myosin motor function. Proc Natl Acad Sci U S A (2013) 1.42
Redirecting valvular myofibroblasts into dormant fibroblasts through light-mediated reduction in substrate modulus. PLoS One (2012) 1.41
Fatty acids identified in the Burmese python promote beneficial cardiac growth. Science (2011) 1.30
Cancer causes cardiac atrophy and autophagy in a sexually dimorphic manner. Cancer Res (2010) 1.30
Soy diet worsens heart disease in mice. J Clin Invest (2006) 1.29
Loaded wheel running and muscle adaptation in the mouse. Am J Physiol Heart Circ Physiol (2005) 1.23
Hydrogels preserve native phenotypes of valvular fibroblasts through an elasticity-regulated PI3K/AKT pathway. Proc Natl Acad Sci U S A (2013) 1.20
Bioinformatics assessment of beta-myosin mutations reveals myosin's high sensitivity to mutations. Trends Cardiovasc Med (2008) 1.20
Cardiac HDAC6 catalytic activity is induced in response to chronic hypertension. J Mol Cell Cardiol (2011) 1.19
Sex modifies exercise and cardiac adaptation in mice. Am J Physiol Heart Circ Physiol (2004) 1.18
Functional diversity among a family of human skeletal muscle myosin motors. Proc Natl Acad Sci U S A (2009) 1.18
Intrathecal polymer-based interleukin-10 gene delivery for neuropathic pain. Neuron Glia Biol (2006) 1.18
Statins block calcific nodule formation of valvular interstitial cells by inhibiting alpha-smooth muscle actin expression. Arterioscler Thromb Vasc Biol (2009) 1.16
Sex-based cardiac physiology. Annu Rev Physiol (2009) 1.13
Pregnancy as a cardiac stress model. Cardiovasc Res (2014) 1.11
MyoD, Myf5, and the calcineurin pathway activate the developmental myosin heavy chain genes. Dev Biol (2006) 1.09
The effects of biological sex and diet on the development of heart failure. Circulation (2007) 1.07
Intracellular calcium and myosin isoform transitions. Calcineurin and calcium-calmodulin kinase pathways regulate preferential activation of the IIa myosin heavy chain promoter. J Biol Chem (2002) 1.07
Identification of functional differences between recombinant human α and β cardiac myosin motors. Cell Mol Life Sci (2012) 1.06
Restoration of CREB function is linked to completion and stabilization of adaptive cardiac hypertrophy in response to exercise. Am J Physiol Heart Circ Physiol (2007) 1.06
Integrin-linked kinase production prevents anoikis in human mesenchymal stem cells. J Biomed Mater Res A (2007) 1.05
Erratum to: Identification of functional differences between recombinant human α and β cardiac myosin motors. Cell Mol Life Sci (2012) 1.01
Myocyte enhancer factor-2 and serum response factor binding elements regulate fast Myosin heavy chain transcription in vivo. J Biol Chem (2005) 1.01
Hypertrophy, fibrosis, and sudden cardiac death in response to pathological stimuli in mice with mutations in cardiac troponin T. Circulation (2004) 0.99
Morphological and functional alterations in ventricular myocytes from male transgenic mice with hypertrophic cardiomyopathy. Circ Res (2003) 0.98
Mutations in the beta-myosin rod cause myosin storage myopathy via multiple mechanisms. Proc Natl Acad Sci U S A (2009) 0.98
Akt and MAPK signaling mediate pregnancy-induced cardiac adaptation. J Appl Physiol (1985) (2012) 0.97
Expression of cardiac troponin T with COOH-terminal truncation accelerates cross-bridge interaction kinetics in mouse myocardium. Am J Physiol Heart Circ Physiol (2004) 0.97
Whole transcriptome analysis of the fasting and fed Burmese python heart: insights into extreme physiological cardiac adaptation. Physiol Genomics (2010) 0.95
Mutations at the same amino acid in myosin that cause either skeletal or cardiac myopathy have distinct molecular phenotypes. J Mol Cell Cardiol (2009) 0.94
Activation of serum/glucocorticoid-induced kinase 1 (SGK1) is important to maintain skeletal muscle homeostasis and prevent atrophy. EMBO Mol Med (2012) 0.94
IIb or not IIb? Regulation of myosin heavy chain gene expression in mice and men. Skelet Muscle (2011) 0.93
Loss of desmin leads to impaired voluntary wheel running and treadmill exercise performance. J Appl Physiol (1985) (2003) 0.93
Yin Yang 1 represses alpha-myosin heavy chain gene expression in pathologic cardiac hypertrophy. Biochem Biophys Res Commun (2005) 0.92
A randomized library approach to identifying functional lox site domains for the Cre recombinase. Nucleic Acids Res (2007) 0.90
The role of Akt/GSK-3beta signaling in familial hypertrophic cardiomyopathy. J Mol Cell Cardiol (2009) 0.90
Increased thermoregulation in cold-exposed transgenic mice overexpressing lipoprotein lipase in skeletal muscle: an avian phenotype? J Lipid Res (2008) 0.90
Fighting fat with muscle: bulking up to slim down. Cell Metab (2008) 0.90
Effects of pathogenic proline mutations on myosin assembly. J Mol Biol (2011) 0.90
Metabolic crosstalk between the heart and liver impacts familial hypertrophic cardiomyopathy. EMBO Mol Med (2014) 0.90
Myosin heavy chain is not selectively decreased in murine cancer cachexia. Int J Cancer (2011) 0.89
Myh7b/miR-499 gene expression is transcriptionally regulated by MRFs and Eos. Nucleic Acids Res (2012) 0.89
Blocking cardiac growth in hypertrophic cardiomyopathy induces cardiac dysfunction and decreased survival only in males. Am J Physiol Heart Circ Physiol (2006) 0.89
Interferon-γ causes cardiac myocyte atrophy via selective degradation of myosin heavy chain in a model of chronic myocarditis. Am J Pathol (2012) 0.88
Calcineurin activity is required for cardiac remodelling in pregnancy. Cardiovasc Res (2013) 0.88
Intrathecal injection of naked plasmid DNA provides long-term expression of secreted proteins. Mol Ther (2008) 0.88
Alterations in mitochondrial function in a mouse model of hypertrophic cardiomyopathy. Am J Physiol Heart Circ Physiol (2002) 0.88
Remodeling the cardiac transcriptional landscape with diet. Physiol Genomics (2011) 0.88
Characterization of cell subpopulations expressing progenitor cell markers in porcine cardiac valves. PLoS One (2013) 0.86
Diversity in transcriptional start site selection and alternative splicing affects the 5'-UTR of mouse striated muscle myosin transcripts. J Muscle Res Cell Motil (2006) 0.86
Serum deprivation improves seeding and repopulation of acellular matrices with valvular interstitial cells. J Biomed Mater Res A (2005) 0.85
Rational promoter selection for gene transfer into cardiac cells. J Mol Cell Cardiol (2003) 0.84
Cell type specific targeted intracellular delivery into muscle of a monoclonal antibody that binds myosin IIb. Mol Immunol (2003) 0.83
Estrogenic compounds are not always cardioprotective and can be lethal in males with genetic heart disease. Endocrinology (2012) 0.83
Distinct cardiac transcriptional profiles defining pregnancy and exercise. PLoS One (2012) 0.82
The superfast human extraocular myosin is kinetically distinct from the fast skeletal IIa, IIb, and IId isoforms. J Biol Chem (2013) 0.82
Acute effects of desmin mutations on cytoskeletal and cellular integrity in cardiac myocytes. Cell Motil Cytoskeleton (2003) 0.82
Interplay between exonic splicing enhancers, mRNA processing, and mRNA surveillance in the dystrophic Mdx mouse. PLoS One (2007) 0.81
Estimate of the abundance of cardiomyopathic mutations in the β-myosin gene. Int J Cardiol (2009) 0.81
A mutation in the beta-myosin rod associated with hypertrophic cardiomyopathy has an unexpected molecular phenotype. Biochem Biophys Res Commun (2009) 0.79
Regulation of physiological and metabolic function of muscle by female sex steroids. Med Sci Sports Exerc (2012) 0.79
Molecular and genetic approaches to studying exercise performance and adaptation. Exerc Sport Sci Rev (2002) 0.79
Immunogenicity of intrathecal plasmid gene delivery: cytokine release and effects on transgene expression. J Gene Med (2009) 0.78
Impaired skeletal muscle regeneration in the absence of fibrosis during hibernation in 13-lined ground squirrels. PLoS One (2012) 0.78
GFP fails to inhibit actin-myosin interactions in vitro. Nat Methods (2008) 0.77
Partnering up for cardiac hypertrophy. Circ Res (2006) 0.77
Myosin filament assembly requires a cluster of four positive residues located in the rod domain. FEBS Lett (2012) 0.76
Measuring microRNA reporter activity in skeletal muscle using hydrodynamic limb vein injection of plasmid DNA combined with in vivo imaging. Skelet Muscle (2013) 0.76
Estrogens mediate cardiac hypertrophy in a stimulus-dependent manner. Endocrinology (2012) 0.76
Frank Ruddle (1929-2013). Am J Hum Genet (2013) 0.75
Mechanisms of the pathogenesis of troponin T-based familial hypertrophic cardiomyopathy. Trends Cardiovasc Med (2003) 0.75
Rescuing cardiac malfunction: the roles of the chaperone-like small heat shock proteins. Circ Res (2008) 0.75
The role of MEKK1 in hypertrophic cardiomyopathy. Int Heart J (2010) 0.75
Task Force on Strategic Research Direction: Basic Science Subgroup key science topics report. Circulation (2002) 0.75
Suppressor tRNAs: protocols and applications for cardiac gene transfer. Methods Mol Biol (2003) 0.75
Direct gene transfer into mouse heart. Methods Enzymol (2002) 0.75